Sustained virological response of pegylated interferon α-2A plus ribavirin in patients with chronic hepatitis C genotype 4

被引：0
|
作者：
Shiha, G
Gabre, M
Zalata, K
Sayed, S
机构：
[1] Mansoura Univ, Fac Med, Dept Internal Med, Mansoura, Egypt
[2] Mansoura Univ, Dept Pathol, Mansoura, Egypt
[3] Tanta Univ, Fac Med, Dept Internal Med, Tanta, Egypt
来源：
GUT | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
316
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [11] Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4
    Martin-Carbonero, L.
    Puoti, M.
    Garcia-Samaniego, J.
    De Luca, A.
    Losada, E.
    Quinzan, G.
    Bruno, R.
    Marino, A.
    Gonzalez, M.
    Nunez, M.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) : 710 - 715
  • [12] GENOTYPE AND DURATION OF THERAPY ARE CRUCIAL FOR SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS RETREATED AFTER RELAPSE FOLLOWING A PREVIOUS COURSE OF PEGYLATED INTERFERON PLUS RIBAVIRIN
    Stern, Christiane
    Martinot-Peignoux, Michelle
    Ripault, Marie-Pierre
    Moucari, Rami
    Asselah, Tarik
    Cardoso, Ana-Carolina
    Boyer, Nathalie
    Bedossa, Pierre
    Marcellin, Patrick
    HEPATOLOGY, 2009, 50 (04) : 686A - 687A
  • [13] Sustained virological response of patients with hepatitis C virus genotype 2 depends on pegylated interferon compliance
    Watanabe, Takao
    Konishi, Ichiro
    Shigematsu, Shuichiro
    Uesugi, Kazuhiro
    Joko, Kouji
    Seike, Hirotaka
    Okada, Shinichi
    Miyaoka, Hiroaki
    Nakanishi, Seiji
    Abe, Masanori
    Matsuura, Bunzo
    Michitaka, Kojiro
    Horiike, Norio
    Hiasa, Yoichi
    Onji, Morikazu
    HEPATOLOGY RESEARCH, 2011, 41 (08) : 722 - 730
  • [14] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4
    El Makhzangy, Hesham
    Esmat, Gamal
    Said, Mohamed
    ElRaziky, Maissa
    Shouman, Soheir
    Refai, Rasha
    Rekacewicz, Claire
    Gad, Rita Raafat
    Vignier, Nicolas
    Abdel-Hamid, Mohamed
    Zalata, Khaled
    Bedossa, Pierre
    Pol, Stanislas
    Fontanet, Arnaud
    Mohamed, Mostafa K.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583
  • [15] Nitric Oxide Levels and Sustained Virological Response to Pegylated-Interferon alpha2a plus Ribavirin in Chronic HCV Genotype 4 Hepatitis: a Prospective Study
    Ibrahim, Mohamed
    Gomaa, Wafaey
    Ibrahim, Yehia
    El Hadad, Hazem
    Shatat, Mohamed
    Aleem, Ashraf Abdel
    Essawy, Mohamed
    Fouad, Yasser M.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2010, 19 (04) : 387 - 392
  • [16] A miRNAs based multivariate signature to predict sustained virological response to pegylated-interferon plus ribavirin treatment in patients with chronic hepatitis C
    Estrabaud, Emilie
    Bieche, Ivan
    Carrat, Fabrice
    Lapalus, Martine
    De Muynck, Simon
    Lada, Olivier
    Martinot-Peignoux, Michelle
    Valla, Dominique
    Bedossa, Pierre
    Marcellin, Patrick
    Vidaud, Michel
    Asselah, Tank
    HEPATOLOGY, 2012, 56 : 687A - 688A
  • [17] Shorter duration of pegylated interferon plus ribavirin therapy for chronic hepatitis c genotype 1 patients who achieve early virological response
    Omesh, Goyal
    Sood, Ajit
    Midha, Vandana
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 18 - 19
  • [18] Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin
    Yen, Yi-Hao
    Wang, Jyh-Chwan
    Hung, Chao-Hung
    Lu, Sheng-Nan
    Wang, Jing-Houng
    Hu, Tsung-Hui
    Kee, Kwong-Ming
    Hsiao, Chang-Chun
    Lee, Chuan-Mo
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (07) : 652 - 658
  • [19] Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6
    Pham, Thuy T.
    Ho, Dat T.
    GASTROENTEROLOGY, 2009, 136 (05) : A840 - A840
  • [20] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
12345